Rigakos Georgios

Rigakos Georgios Internist Oncologist

3rd Department of Medical Oncology HYGEIA

Education & Academic Qualifications

  • M.Sc. in Molecular Medicine, University of Athens, Medical School, Athens 2010
  • M.D. with distinction (Honours Degree) University of Athens, Medical School, Athens, Greece 2003 


Fellowship in Societies, Membership in Journal Editorial Committees

  • SMO Examination Certificate (September 2014)

  • Specialty of medical oncology certification (July 2014)

  • GMC full registration (ref no 7449906)


Work Experience

  • Consultant in Medical Oncology – 3rd Dept of Medical Oncology, “Hygeia” hospital, Athens September 1, 2014 – present

  • Medical Oncology locum Sp. Reg.  – Gynae/renal/melanoma unit (Dr. Susanna Banerjee) Royal Marsden Hospital, London Sept, 2013 –July  , 2014

  • Medical Oncology Sp.Reg. – University of Athens, Medical School “ALEXANDRA” hospital, Department of Medical Oncology (Prof. A.M. Dimopoulos), May 26, 2011 – June 17, 2014

  • Internal Medicine SHO/Sp.Reg (including 6 months in Hematology) – University of Athens, Medical School, “LAIKO” University hospital (Prof. H. Moutsopoulos), June 20, 2008 – May 25, 2011.

  • Associate assistant in medical oncology private practice (Dr. E. Razis), May 2008 – Sept 9, 2013.

  • Post Graduate training program in Medical Oncology (attending with scholarship) Hygeia Hospital, 1st Department of Medical Oncology ( Dr. E. Razis) December 1, 2007 – April 1, 2008

  • Post graduate training course in Molecular Medicine (M.Sc.) Molecular Carcinogenesis group (Prof V. Gorgoulis), Department of Histology and Embryology, Medical School, University of Athens February 1, 2007 – May 31, 2008

  • Rural Community Service – General Hospital, Molaoi Lakonia, Greece, September 1, 2005 – January 31, 2007

  • Army Service – Medical Officer February 24, 2004 – November 24, 2004


Clinical & Research Interest

  • Lung Cancer

  • GI Cancer

  • Head Neck Cancer

  • CNS tumors


Honors & Awards

  • Scholarship with a grant from Hellenic Society of Medical Oncology for training in oncology at Royal Marsden, London, UK

  • 1st place in final exams of Hellenic Boards of Oncology (EAKO)

  • University of Athens scholarship for excellent performance in post graduate training course in Molecular Medicine (M.Sc.), Athens 2010

  • University of Athens scholarship for excellent performance in academic year 1998-1999

  • Merit in Anatomy examination for excellent performance (1999)

  • Scholarship from “Geroulakeio” foundation of Sparti, Greece to study in the Medical School of Athens

  • Merit for achieving highest graduating results of all high school students in Lakonia prefecture  (1997) 


Recent Publications

  • Bevacizumab in high grade glioma: Is there a subgroup that benefits?  G.Rigakos, A.Kyriazoglou, A.Vernadou, S.Papadopoulos, E.Skarpidi, P.Nomikos, C.Dardoufas, G.Nassioulas, G.Kouvatseas, O.Spyri, S.Labropoulos, E.Razis. (2017) Hematol Med Oncol, Volume 2(4): 1-7.

  • Extracranial and diffuse bone marrow metastases from Anaplastic Oligodendroglioma: a case report and review of the literature. A.Assi, A.Huang, G.Rigakos, S.Papadopoulos, Th.Georgiadis, E.Vrakidou, C.Dardoufas, S.Lampropoulos, P.Nomikos, E.Razis. Neuro-Oncology Practice (submitted 2016).

  • Cancer of unknown primary ultimately diagnosed as male breast cancer: A rare case report. G.Rigakos, A.Vakos, S.Papadopoulos, A.Vernadou, A.Tsimpidakis, D. Papachristou, E.Razis Molecular and Clinical Oncology. 5: 263-266, 2016.

  • Neoplastic meningitis: clinical presentation, differential diagnosis, radiology, diagnosis. G.Rigakos, C.Liakou, N.Felipe, D.Orkoulas-Razis, E.Razis. Cancer Control (under press).

  • Unusual .mandibular metastasis of bladder cancer in a patient and two synchronous malignancies, bladder cancer and chronic lymphocytic leukemia, in a single lymph node. A case report. C.Liakou, M.Georgiou, T.Georgiadis, G.Rigakos, S. Lampropoulos, E.Razis. Case Reports in Clinical Pathology, 2015, Vol. 2, No. 4.

  • Brain Tumors. G.Rigakos, E.Razis. The Doctor. 2015:18:64-65.

  • EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with wt-KRAS metastatic colorectal cancer treated with Cetuximab. E.Razis, G.Pentheroudakis, G.Rigakos, M.Bobos, G.Kouvatseas, O.Tzaida, T.Makatsoris, P.Papakostas, M.Bai, A.Goussia, E.Samantas, D.Papamichael, O.Romanidou, I.Efstratiou, E.Tsolaki, A.Psyrri, W.De Roock, D.Bafaloukos, G.Klouvas, S.Tejpar, K.T. Kalogeras, D.Pectasides, G.Fountzilas. Journal of Cancer Research and Clinical Oncology. 2014 Mar, doi: 10.1007/s00432-014-1626-2. Epub 2014 Mar 5.

  • Newer Therapeutic Agents for Urogenital System Tumors. F.Stavridi, G.Rigakos, E.Razis. Journal of Medical Annals (Hygeia Hospital Monthly Edition), 2012; 16(3): 791-795.

  • BRCAness: Finding the Achilles Heel in Ovarian Cancer. G.Rigakos E.Razis. Oncologist. 2012;17(7):956-62. Epub 2012 Jun 6.

  • Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer. Razis E, Bobos M, Kotoula V, Eleftheraki AG, Kalofonos HP, Pavlakis K, Papakostas P, Aravantinos G, Rigakos G, Efstratiou I, Petraki K, Bafaloukos D, Kostopoulos I, Pectasides D, Kalogeras KT, Skarlos D, Fountzilas G. Breast Cancer Res Treat. 2011 Jul;128(2):447-56. Epub 2011 May 19.